Foot and mouth disease resistant cattle biotechnology governance

Introduction

Foot and mouth disease (FMD) is a highly contagious viral disease affecting cattle, buffaloes, sheep, goats and other cloven-hoofed animals. It can cause serious economic losses through reduced milk production, impaired animal growth, restrictions on livestock movement and international trade limitations.

Biotechnology offers new possibilities for developing cattle with improved resistance to FMD. Genetic engineering, gene editing, molecular diagnostics and advanced vaccine technologies may contribute to disease prevention and control. However, developing disease-resistant cattle requires appropriate scientific supervision, animal welfare protection, biosafety assessment and regulatory approval.

In India, biotechnology governance concerning FMD-resistant cattle operates within the broader framework of animal health legislation, environmental regulation and agricultural biotechnology policies.

Meaning and importance of biotechnology governance

Biotechnology governance refers to the legal, institutional and ethical framework controlling the development, testing and application of biotechnology involving living organisms.

In the context of FMD-resistant cattle, governance ensures that genetic modifications are scientifically justified, animal welfare is protected and possible environmental consequences are assessed.

Its major objectives include:

Preventing the spread of infectious diseases.

Improving livestock health and productivity.

Protecting biodiversity and indigenous cattle breeds.

Ensuring responsible genetic modification.

Maintaining food safety and public confidence.

Supporting sustainable livestock development.

Disease resistance should also be distinguished from complete immunity. A genetically modified animal may show improved resistance without being completely protected against infection.

Legal framework in India

1. Prevention and Control of Infectious and Contagious Diseases in Animals Act, 2009

This Act provides a statutory framework for preventing, controlling and managing infectious and contagious animal diseases.

It empowers authorities to undertake measures concerning disease notification, veterinary inspection, vaccination, movement restrictions and disease-control operations.

FMD control programmes must operate consistently with applicable requirements under this legislation.

2. Environment (Protection) Act, 1986

The Environment (Protection) Act provides the principal statutory basis for regulating genetically engineered organisms.

Section 6 empowers the Central Government to make rules concerning hazardous substances and environmental protection.

The Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms/Genetically Engineered Organisms or Cells Rules, 1989, establish the regulatory framework for specified activities involving genetically engineered organisms.

If cattle are genetically engineered or gene-edited, the applicability of these Rules must be examined according to the organism, modification and relevant exemptions.

3. Biological Diversity Act, 2002

The Biological Diversity Act regulates access to biological resources and associated traditional knowledge, subject to applicable exemptions.

Research involving indigenous cattle genetic resources may raise questions concerning conservation, access permissions and benefit-sharing obligations.

4. Prevention of Cruelty to Animals Act, 1960

The Act provides legal protection against unnecessary pain and suffering to animals.

Section 11 identifies different forms of cruelty. Biotechnology research involving cattle must therefore consider animal welfare, appropriate veterinary supervision and protection against unnecessary suffering.

5. DBT Guidelines, 2022

The Department of Biotechnology's Guidelines for the Safety Assessment of Genome Edited Plants, 2022, specifically concern plants and should not be treated as a regulatory exemption for gene-edited cattle.

Genetically engineered animals require assessment under the applicable animal biotechnology and biosafety framework.

Regulatory oversight and institutional responsibilities

Several institutions may have responsibilities in the governance of FMD-resistant cattle biotechnology.

1. Department of Biotechnology (DBT): Supports biotechnology research and develops relevant scientific and biosafety policies.

2. Review Committee on Genetic Manipulation (RCGM): Reviews specified research and development activities involving genetically engineered organisms.

3. Genetic Engineering Appraisal Committee (GEAC): Performs functions assigned under the 1989 Rules concerning activities involving environmental release and other regulated matters.

4. Department of Animal Husbandry and Dairying: Coordinates national animal disease prevention, livestock health and disease-control programmes.

5. Institutional Animal Ethics Committees: Provide ethical oversight for animal experiments where required under applicable animal research regulations.

These institutions have different legal responsibilities. Research funding, animal health supervision and environmental approval should not be treated as interchangeable permissions.

Major governance considerations

1. Genetic modification assessment

Authorities should evaluate the nature of the genetic modification, its intended characteristics and possible unintended biological effects.

2. Animal welfare protection

Research involving cattle must comply with animal welfare requirements. Scientific benefits cannot justify unnecessary suffering or inadequate veterinary care.

3. Disease surveillance

Disease-resistant cattle must remain part of appropriate veterinary surveillance systems. Genetic resistance should not replace established vaccination and disease-control programmes.

4. Food safety

Where products such as milk or meat are obtained from genetically modified cattle, applicable food safety and regulatory requirements must be considered before commercial distribution.

5. Environmental protection

Authorities should examine possible effects on indigenous cattle populations, genetic diversity and the wider agricultural environment.

6. Traceability and accountability

Research institutions should maintain records concerning animal identity, genetic characteristics, experimental approvals and relevant health information.

Important judicial decisions

1. Animal Welfare Board of India v. A. Nagaraja (2014)

The Supreme Court emphasised animal welfare, dignity and protection against unnecessary suffering. It recognised that animals should not be treated merely as objects of human use.

This judgment is relevant to biotechnology research involving cattle because genetic modification and experimentation must respect animal welfare principles.

2. Animal Welfare Board of India v. Union of India (2023)

The Supreme Court considered the legal framework governing amendments to animal-related legislation concerning traditional animal sports. The judgment discussed legislative authority and the importance of animal welfare protections.

Its principles are relevant to understanding the relationship between animal welfare legislation and activities involving genetically modified livestock.

3. Vellore Citizens' Welfare Forum v. Union of India (1996)

The Supreme Court recognised the precautionary principle as part of Indian environmental law. This principle supports careful assessment of uncertain environmental consequences before permitting potentially risky biotechnology activities.

4. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

The Supreme Court highlighted the importance of scientific expertise in environmental decision-making. This principle is relevant when authorities evaluate complex genetic technologies and their potential environmental effects.

There is no widely recognised Indian Supreme Court judgment directly addressing genetically engineered FMD-resistant cattle. These decisions provide analogous principles concerning animal welfare, environmental precaution and scientific regulatory assessment.

Challenges and recommendations

The governance of FMD-resistant cattle biotechnology faces challenges involving scientific uncertainty, regulatory coordination, animal welfare and the conservation of indigenous breeds.

The government should strengthen specialised veterinary biotechnology research, establish transparent approval procedures and improve coordination between animal health and environmental authorities. Independent animal welfare review and long-term disease surveillance should also be maintained.

Furthermore, biotechnology policies should ensure that small dairy farmers can benefit from scientific developments without becoming excessively dependent on expensive technologies or proprietary genetic resources.

Conclusion

Biotechnology governance concerning FMD-resistant cattle is important for improving livestock health while protecting animal welfare, biodiversity and public health. India's animal disease legislation, Environment (Protection) Act, 1986, Biological Diversity Act, 2002 and Prevention of Cruelty to Animals Act, 1960 provide important legal safeguards. Judicial decisions concerning animal welfare and environmental precaution strengthen the regulatory framework. Responsible development requires scientific assessment, institutional supervision, veterinary monitoring and transparent accountability.